Delivery Order SPE2DB22D3501-SPE2DB25FWE91
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,181.29 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nateglinide 60 mg tablets (100-count units) with a ceiling value of $1,554.62. This firm fixed-price delivery order, which has a completion date of September 10, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading pharmaceutical distributors and serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets in quantities of 100 on August 5, 2025, with completion targeted for August 6, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $1,573.16 and operates under firm fixed price terms. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the awardee location....
- The Defense Logistics Agency awarded a delivery order valued at $2,919.52 to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets (100-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Nateglinide is a rapid-acting insulin secretagogue used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $1,694.90 to AmerisourceBergen Drug Corp for 100 tablets of Nateglinide 60 mg, an oral antidiabetic medication. This competitive, non-set-aside delivery order, effective through September 18, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location under firm fixed price terms. The award represents a child contract action under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Nateglinide 60 mg tablets in quantities of 100 units, with a contract ceiling value of $6,925.84 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nateglinide is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,181.48 firm-fixed-price delivery order is for the supply of 4,568,061,670 units of the prescription medication Nateglinide 120 mg tablets. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award....
- This federal contract award, valued at $1,842.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,875,756 units of the medication Nateglinide 60 mg Tablet in 100-count packages. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 11, 2025. It is not designated as a set-aside contract,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,444.50 firm fixed price delivery order is for the provision of 4,564,118,866 units of the pharmaceutical drug Nateglinide 120 mg tablets. The contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp's Corporate Office division located in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,867.35 firm fixed-price delivery order is for the supply of Nateglinide 120 mg tablets, with a completion date of August 8, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWE91Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,475.49 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) under a firm fixed price contract. The award was issued on June 26, 2025, with an ultimate completion date of June 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a routine pharmaceutical procurement action within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. Nateglinide, a diabetes management medication, aligns with the company's extensive portfolio of therapeutic pharmaceuticals delivered through competitively awarded federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 6/26/25 |